Sphingosine 1-phosphate interferes on the differentiation of human monocytes into competent dendritic cells

Scandinavian Journal of Immunology

Volumn 65, Issue 1, 2007, Pages 84-91

  Martino, A ^a   Volpe, E ^b,c   Auricchio, G ^d   Izzi, V ^c   Poccia, F ^a   Mariani, F ^b   Colizzi, V ^c   Baldini, P M ^c  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; SPHINGOSINE 1 PHOSPHATE; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CD4+ CD45+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD1; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; HUMANS; LIPOPOLYSACCHARIDES; LYSOPHOSPHOLIPIDS; MONOCYTES; RNA, MESSENGER; SPHINGOSINE; T-LYMPHOCYTES;

EID: 33845720183     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01860.x     Document Type: Article

References (41)

1. Pyne S, Pyne J. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 2000;349:385-402.
2. Spiegel S. Sphingosine 1-phosphate: a ligand for EDG-1 family of G coupled receptors. Ann N Y Acad Sci 2000;905:54-60.
3. Pettus BJ, Chalfant CE, Hannun YA. Sphingolipids in inflammation: roles and implications. Curr Mol Med 2004;4:405-18.
4. Lightle SA, Oakley JI, Nikolova-Karakashian MN. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging. Mech Ageing Dev 2000;120:111-25.
5. Suzuki E, Handa K, Toledo MS, Hakomori S. Sphingosine-dependent apoptosis: a unified concept based on multiple mechanisms operating in concert. Proc Natl Acad Sci U S A 2004;101:14788-93.
6. Spiegel S, Milstien S. Sphingosine 1 phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003;4:397-07.
7. Yatomi Y, Igarashi Y, Yang L et al. Sphingosine-1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem 1997;121:969-73.
8. Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 1993;291:677-80.
9. Mastrandrea LD, Sessanna SM, Laychock SG. Sphingosine kinase activity and sphingosine-1 phosphate production in rat pancreatic islets and INS-1 cells: response to cytokines. Diabetes 2005;54:1429-36.
10. Merrill AH Jr, Schmelz EM, Dillehay DL et al. Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 1997;142:208-25.
11. Xu C, Schwartz-Hansen J, Edvinsson L. Sphingosine signalling and atherogenesis. Acta Pharmacol Sin 2004;25:849-54.
12. Ludewig B, Laman JD. The in and out of monocytes in atherosclerotic plaques: balancing inflammation through migration. Proc Natl Acad Sci U S A 2004;101:11529-30.
13. Ludewig B, Krebs P, Scandella E. Immunopathogenesis of atherosclerosis. J Leukoc Biol 2004;76:300-6.
14. Olivera A, Rivera J. Sphingolipids and the balancing of immune cell function: lessons from the mast cell. J Immunol 2005;174:1153-8.
15. Ammit AJ, Hastie AT, Edsall LC et al. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J 2001;15:1212-4.
16. Goetzl EJ, Rosen H. Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J Clin Invest 2004;114:1531-7.
17. Idzko M, Panther E, Corinti S et al. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature dendritic cells for emergence of Th2 immune responses. FASEB J 2002;16:625-7.
18. Banchereau J, Steinman R. Dendritic cells and the control of the immunity. Nature 1998;392:245-52.
19. Banchereau J, Schuler-Thurner B, Palucka AK, Schuler G. Dendritic cells as vectors for therapy. Cell 2001;392:271-4.
20. Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001;106:263-6.
21. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997;9:10-6.
22. Banchereau J, Briere F, Caux C. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
23. Lanzavecchia A, Sallusto F. The instructive role of dendritic cells on T-cell responses: linearity, plasticity and kinetics. Curr Opin Immunol 2001;13:291-8.
24. Randolph GJ, Bealieu S, Lebecque S, Steinman RM, Muller WA. Differentiation of monocytes into dendritic cells in a model of trans-endothelial trafficking. Science 1998;284:480-3.
25. + dendritic cells. Proc Natl Acad Sci U S A 1996;93:2588-92.
26. Delneste Y, Charbonnier P, Herbault N et al. Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood 2003;101:143-50.
27. Chomarat P, Banchereau J, Davoust J, Palucka AK. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 2000;1:510-4.
28. Martino A, Sacchi A, Sanarico N et al. Dendritic cells derived from BCG-infected precursors induce Th2-like immune response. J Leukoc Biol 2004;76:827-34.
29. Martino A, Sacchi A, Volpe E et al. Non-pathogenic Mycobacterium smegmatis induces the differentiation of human monocytes directly into fully mature dendritic cells. J Clin Immunol 2005;25:365-75.
30. + monocytes through distinct pathways that activate NK-kB. J Immunol 2000;165:3647-55.
31. Navarro Péguet J, Sportouch M, Popa I, Berthier O, Schmitt D, Portoukalian J. Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis. J Immunol 2003;170:3488-94.
32. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 1997;27:431-41.
33. Chomczynski P, Sacchi N. Single-step method of RNA isolation by guanidium thiocyanate phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
34. -ΔΔCt method. Methods 2001;25:402-8.
35. Goswami S, Sahai E, Wyckoff JB et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005;65:5278-83.
36. Patterson S, Donaghy H, Amjadi P, Gazzard B, Gotch F, Kelleher P. Human BDCA-1-positive blood dendritic cells differentiate into phenotypically distinct immature and mature populations in the absence of exogenous maturational stimuli: differentiation failure in HIV infection. J Immunol 2005;174:8200-9.
37. Trinchieri G, Scott P. The role of interleukin-12 in the immune response, disease and therapy. Immunol Today 1994;15:460-3.
38. - dendritic cell subsets differ in their cytokine production profiles, susceptibility to transfection, and capacities to direct Th cell differentiation. J Immunol 2000;165:3584-91.
39. Cappello F, Rappa F, Anzalone R, La Rocca G, Zummo G. CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer. Br J Cancer 2005;92:888-90.
40. La Rocca G, Anzalone R, Bucchieri F, Farina F, Cappello F, Zummo G. CD1a and antitumour immune response. Immunol Lett 2004;95:1-4.
41. Cappello F, Rappa F, Bucchieri F, Zummo G. CD1a: a novel biomarker for Barrett's metaplasia? Lancet Oncol 2003;4:497.